Skip to Content

GS JT (Votrient pazopanib 200 mg)

Generic Name: pazopanib

Pill with imprint GS JT is Gray, Capsule-shape and has been identified as Votrient pazopanib 200 mg. It is supplied by GlaxoSmithKline.

Votrient is used in the treatment of soft tissue sarcoma; renal cell carcinoma and belongs to the drug class VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Votrient pazopanib 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GS JT

Votrient

Generic Name:
pazopanib
Imprint:
GS JT
Strength:
pazopanib 200 mg
Color:
Gray
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
GlaxoSmithKline
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
povidone
sodium starch glycolate type A potato
hypromelloses
ferrosoferric oxide
polyethylene glycol 400
polysorbate 80
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
00078-0670 Novartis Pharmaceuticals Corporation

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide